Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
3.490
-0.060 (-1.69%)
At close: Feb 27, 2026, 4:00 PM EST
3.470
-0.020 (-0.57%)
After-hours: Feb 27, 2026, 7:43 PM EST

Neumora Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Neumora Therapeutics stock have an average target of 8.00, with a low estimate of 1.00 and a high estimate of 18. The average target predicts an increase of 129.23% from the current stock price of 3.49.

Analyst Consensus: Buy
Target Low Average Median High
Price $1.00 $8.00 $8.00 $18
Change -71.35% +129.23% +129.23% +415.76%
* Price targets were last updated on Jan 12, 2026.

Analyst Ratings

The average analyst rating for Neumora Therapeutics stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Sep '25Oct '25Nov '25Dec '25Jan '26Feb '26
Strong Buy 233333
Buy 111234
Hold 322111
Sell 222222
Strong Sell 000000
Total 8888910

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
William Blair
William Blair
Buy
Upgrades
n/a
Buy Upgrades n/a n/a Feb 17, 2026
Leerink Partners
Leerink Partners
Buy
Initiates
$8
Buy Initiates $8 +129.23% Jan 12, 2026
RBC Capital
RBC Capital
Buy
Upgrades
$4$7
Buy Upgrades $4$7 +100.57% Dec 1, 2025
Stifel
Stifel
Hold
Maintains
$2$3
Hold Maintains $2$3 -14.04% Nov 17, 2025
Needham
Needham
Strong Buy
Maintains
$6$8
Strong Buy Maintains $6$8 +129.23% Oct 28, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.45
from -1.53
EPS Next Year
-1.03
from -1.45
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
-------
Revenue Growth
-------
EPS
-7.64-10.84-4.81-3.63-1.53-1.45-1.03
EPS Growth
-------
Forward PE
-------
No. Analysts -----1111
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027202820292030
High -1.42 -0.82
Avg -1.45 -1.03
Low -1.44 -1.42

EPS Growth

EPS Growth 202520262027202820292030
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.